EUVIMEDEUVIMED entdecken
Crossref

Impact of the 3rd Edition of the Bethesda System for Reporting Thyroid Cytopathology on Grey Zone Categories

Sofia Cuco Guerreiro, Ebru Tastekin, Mariana Mourao, Isabel Loureiro, Rosario Eusebio, Hugo Pinto Marques, Meltem Oznur, Can Kosti Caliskan, Fernando C Schmitt, Massimo Bongiovanni, Sule Canberk

Acta Cytologica · 2023

DOI: 10.1159/000534884 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Cytologica, 2023. Verfasst von Sofia Cuco Guerreiro und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Centro Hospitalar Universitário Lisboa Central, Hospital Curry Cabral, Lisbon, Portugal. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroid Nodule, Adenocarcinoma, Follicular. Die Arbeit wurde bisher 8-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Thyroid Bethesda Reporting System is a six-tiered system that aims to bring uniformity in reporting thyroid cytology and improve the communication with clinicians. The system has achieved its goal as a presurgical diagnostic method; however, it remains a screening method in the grey zone categories, namely atypia of undetermined significance (AUS) and follicular neoplasm (FN). The book recently released the 3rd edition, following the recent changes in thyroid pathology. One of the most important novelties is subgrouping AUS category and FN to be able to make a better risk stratification in these categories. Our group aims to retrospectively analyze a large dataset based on the new TBSRTC, with a focus on the grey zone categories.

Methods

Only patients who underwent lobectomy or total thyroidectomy were included, allowing for direct comparison between cytological and histopathological results. Cytological evaluations, based on the TBSRTC 3rd edition, were methodically compared with their respective histopathological results, enabling a comprehensive analysis.

Results

Of the 244 patients (female:male ratio = 8.8:1, mean age = 56), a total of 252 nodules were evaluated. A distinction was noted with 79 nodules (31%) diagnosed as AUS and 173 nodules (69%) as FN. Intriguingly, the risk of malignancy (ROM) for AUS-overall stood at 44.3%, with AUS-nuclear atypia at 50% and AUS-other at 43.2%. Although the AUS subdivisions did not demonstrate statistical significance, a significant disparity was observed in their distribution, with 15% as AUS-nuclear atypia compared to 85% as AUS-other. This disparity raises the question: Could AUS-other be considered the new waste-basket category in the TBSRTC 3rd edition? Using the TBSRTC 3rd edition as a base, we added a subclassification for FN nodules based on the presence or absence of papillary thyroid carcinoma (PTC) nuclear features. Our findings showed that differentiating FN with oncocytic characteristics correlated well with histological outcomes and ROMs. Though retrospective in design with inherent bias potential, our data suggest a possible improvement in PTC case segregation in the FN category when differentiating between FN nodules with and without PTC nuclear features.

Conclusion

Our retrospective study sheds light on the potential advantages of the TBSRTC 3rd edition, particularly in refining the AUS and FN categories for thyroid nodules. The clear disparity in AUS subcategories raises important questions about their classification and potential future refinements. Moreover, the differentiation of FN nodules based on PTC nuclear features holds a promising approach for better risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsThyroid NoduleAdenocarcinoma, FollicularHumansMaleFemaleMiddle AgedRetrospective StudiesBiopsy, Fine-NeedleThyroid Cancer, Papillary

Stichwörter der Autor:innen

AUSBethesda – thyroid classificationBethesda – thyroid cytopathologyFNGrey zone categories of TBSRTCSubcategorization of TBSRTCThyroid – cytologyThyroid – fine-needle aspiration

Autor:innen und Institutionen

  • Department of General Surgery, Centro Hospitalar Universitário Lisboa Central, Hospital Curry Cabral, Lisbon, Portugal.
  • Department of Pathology, Faculty of Medicine, Trakya University, Edirne, Turkey.
  • NOVA National School of Public Health, Public Health Research Center (CISP), Comprehensive Health Research Center, NOVA University of Lisbon, Lisbon, Portugal.
  • Department of General Surgery, Centro Hospitalar de Setúbal, Setubal, Portugal.
  • Hepato-Biliary-Pancreatic and Transplantation Center, Curry Cabral Hospital, Lisbońs Central Hospitals and University Center, And NOVA Medical School, Lisbon, Portugal.
  • Department of Pathology, Faculty of Medicine, Tekirdag Namik Kemal University, Tekirdag, Turkey.

Zitieren

APA

Guerreiro, S. C., Tastekin, E., Mourao, M., Loureiro, I., Eusebio, R., Marques, H. P., Oznur, M., Caliskan, C. K., Schmitt, F. C., Bongiovanni, M., & Canberk, S. (2023). Impact of the 3rd Edition of the Bethesda System for Reporting Thyroid Cytopathology on Grey Zone Categories. Acta Cytologica. https://doi.org/10.1159/000534884

Vancouver

Guerreiro SC, Tastekin E, Mourao M, Loureiro I, Eusebio R, Marques HP, et al. Impact of the 3rd Edition of the Bethesda System for Reporting Thyroid Cytopathology on Grey Zone Categories. Acta Cytologica. 2023. doi:10.1159/000534884

BibTeX
@article{Guerreiro2023,
  author = {Guerreiro, Sofia Cuco and Tastekin, Ebru and Mourao, Mariana and Loureiro, Isabel and Eusebio, Rosario and Marques, Hugo Pinto and Oznur, Meltem and Caliskan, Can Kosti and Schmitt, Fernando C and Bongiovanni, Massimo and Canberk, Sule},
  title = {Impact of the 3rd Edition of the Bethesda System for Reporting Thyroid Cytopathology on Grey Zone Categories},
  journal = {Acta Cytologica},
  year = {2023},
  doi = {10.1159/000534884}
}
Kostenlos starten →